Subscribe: Market Wire - Medical and Healthcare: Medical Devices
http://img.marketwire.com/rss/mwMHMD.rss
Preview: Market Wire - Medical and Healthcare: Medical Devices

Marketwired - Medical Devices



Marketwired - Medical Devices



Last Build Date: Tue, 19 Sep 2017 19:04:02 EDT

Copyright: Copyright: (C) Marketwired
 



Dr. Ellen Turner, Dermatologist in Dallas, TX, To Feature "Best of 2017" Treatments in Exclusive October Showcase

Tue, 19 Sep 2017 18:30:00 EDT

As part of her efforts to continually educate patients and provide them with the most effective treatment protocols that cosmetic dermatology has to offer, dermatologist Dr. Ellen Turner is hosting "Showcase Showdown" at her Dallas practice on Oct. 26, 2017




Dr. Patrick M. Fratellone Joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor

Tue, 19 Sep 2017 10:30:00 EDT

HICKSVILLE, NY--(Marketwired - Sep 19, 2017) - Canbiola, Inc. (OTC PINK: CANB) announced today that the company has added Dr. Fratellone to its Medical Advisory Board and engaged Dr. Fratellone as a distributor for Canbiola products. Dr. Fratellone is an attending physician at St. Luke's Hospital, Roosevelt Hospital, and Beth Israel Hospital, and current professor at University of Bridgeport College of Naturopathic Medicine. In addition, he bridges East Meets West at the Center of Excellence in Bridgeport CT with author Dr. Peter D'Adamo of Eat Right for Your Blood Type. Dr. Fratellone has appeared on multiple shows, and is considered an expert in his field as well a visionary. Dr. Fratellone stated, "As one of the few MDs in the US who is also a registered herbalist, I believe in traditional and time honored treatments, but also to look outside of the box; to that end CBD is certainly part of the future in my opinion with clear benefits to patients. I look forwarded to working with Canbiola, as well as educating the public on the vast benefits of CBD through blogs and speaking engagements."




FDA Grants ALRT Clearance for Insulin Dose Adjustment (IDA) Feature

Tue, 19 Sep 2017 10:02:29 EDT

IDA is designed to ensure that patients get an effective and timely insulin dose(s) based on accurate data about their specific needs




The Qt Company Joins AdvaMed and MassMEDIC to Guide Policy and Technology Innovation in the Medical Device Industry

Tue, 19 Sep 2017 09:00:00 EDT

Software Development Company to Drive Technology Advancements Within the Medical Device Community and Advise on Standards and Regulations on a Global Scale




Pivot Pharma Looks to Improve Cannabinoid Bioavailability with Topical BiPhasix(TM) Delivery System -- CFN Media

Tue, 19 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 19, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) and its recent acquisition of the BiPhasixT Transdermal Drug Delivery technology for the delivery of cannabinoids.




Medovex Corporation Launches DenerveX System in Spain with Distributor Prim SA

Tue, 19 Sep 2017 08:30:00 EDT

Training and First Order Scheduled for Week of September 19th




Rennova Health Announces Big South Fork Medical Center Provided Services to Over 1,000 Patients in First Month of Operation

Tue, 19 Sep 2017 08:30:00 EDT

WEST PALM BEACH, FL--(Marketwired - September 19, 2017) - Rennova Health, Inc. (NASDAQ: RNVA) (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces that Big South Fork Medical Center's Emergency Room has received 1,005 visits in its first month of operation and admitted 45 patients for overnight stays.




Cannabis Science "Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids" Full Publication Released Today In Frontiers In Oncology

Tue, 19 Sep 2017 08:18:05 EDT

IRVINE, CA--(Marketwired - Sep 19, 2017) -  Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces the full publication of initial research results on using nanoparticle drones to target lung cancer with radiosensitizers and cannabinoids in the world-renowned cancer research journal, Frontiers in Oncology, released today.




Pharmacology to Payer: One Quantitative Drug Development Framework to Rule Them All

Tue, 19 Sep 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - September 19, 2017) - This webinar will discuss how "pharmacology to payer" (P2P) can be used as a quantitative framework that bridges the disciplines of pharmacology, epidemiology, and health economics to support meaningful dialogue between industry, regulators, and payers.




Biologics in Dermatology: Considerations for Patients and Clinical Trials, New Webinar Hosted by Xtalks

Tue, 19 Sep 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - September 19, 2017) - In an upcoming presentation experts Darcee Duke Strube, Senior Vice President of Novella Clinical's Dermatology Division and Dr. James J Milbauer, Dermatologist, Medical Monitor and Advisor will discuss the evolution of biologics within the dermatology landscape, with an emphasis on clinical trial considerations for sponsors developing biologic agents.




MetLife Hong Kong Expands Coverage for People with Diabetes and Introduces Insurtech Solution

Tue, 19 Sep 2017 05:21:20 EDT

HONG KONG, CHINA--(Marketwired - Sep 19, 2017) - MetLife Hong Kong* announced today that it has extended the scope of its "MetLife Health-is-Wealth Medical Plan" to include people living with diabetes, and offered its customers insurtech solutions for proactive health management. For the 1 in 10 people in Hong Kong living with diabetes, finding insurance cover that provides comprehensive coverage has historically been a challenge. MetLife Hong Kong's inclusive action will make medical protection more accessible to this group of people.




Industry Leader, Darren Cherry, Leads Advantis Corp. Into the Future

Tue, 19 Sep 2017 01:53:03 EDT

NEWPORT BEACH, CA--(Marketwired - Sep 19, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) announced that it has agreed with leading wholesale, marketing, and logistics expert, Darren Cherry, to take the helm as its new CEO.




FRDJ et la Financière Sun Life font équipe pour amasser des fonds destinés à la recherche sur le diabète

Mon, 18 Sep 2017 16:33:42 EDT

La Révolution FRDJ Roulons met les Canadiens au défi de se dépasser et de récolter de l'argent pour vaincre le diabète de type 1




JDRF and Sun Life Financial team up to raise funds for diabetes research

Mon, 18 Sep 2017 16:33:07 EDT

The JDRF Revolution Ride challenges Canadians to go further and raise funds to defeat type 1 diabetes




Medigus Announces Second Quarter 2017 Financial Results

Mon, 18 Sep 2017 16:05:00 EDT

OMER, ISRAEL--(Marketwired - Sep 18, 2017) - Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and direct visualization technology, today announced financial results for the second quarter ended June 30, 2017.




Pressure BioSciences' Next-Generation Barocycler 2320EXTREME Named a Finalist in the Prestigious 2017 R&D 100 Awards

Mon, 18 Sep 2017 09:46:37 EDT

Considered Among the Most Prestigious Recognitions of Invention and Innovation Worldwide, the R&D 100 Awards Identify the Top 100 Revolutionary Technologies of the Past Year




GeoVax Provides Update on its Zika Vaccine Development

Mon, 18 Sep 2017 09:00:00 EDT

Presentation Made During 11th Vaccine Congress in San Diego




MediXall Group, Inc. Creates Multiple Revenue Streams in September 2017

Mon, 18 Sep 2017 08:00:00 EDT

FT. LAUDERDALE, FL--(Marketwired - Sep 18, 2017) - MediXall Group, Inc. (OTCQB: MDXL) announced today that three additional revenue streams are in place and operational, creating additional value in the company. The mission of the MediXall Group is to revolutionize the medical industry by improving communication; providing better technology and support services; and enabling more efficient, cost-effective healthcare for the consumer. Prior to the planned October launch of the MediXaid Healthcare Platform, a subsidiary of MediXall Group with over 3,500 practitioners and diagnostic centers participating, to date, the company has signed agreements with strategic partners, SafeRide and PWeR®, who offer strong solutions to help network practitioners grow their businesses.




Titan Medical and Florida Hospital Nicholson Center Announce the World's First Installation of Sport Surgical System

Mon, 18 Sep 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - September 18, 2017) - Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), and Florida Hospital Nicholson Center announce the installation of Titan Medical's SPORT Surgical System at the hospital's training facility in Celebration, Florida. This is the first installation in the world for pre-clinical feasibility and validation studies of the SPORT Surgical System, a single port robotic system.




What Does it Take to Successfully Execute Large, Global, Phase III Programs?

Mon, 18 Sep 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - September 18, 2017) - In a complimentary webinar taking place on Tuesday, October 3, 2017 at 10am EDT (3pm BST/UK), INC Research/inVentiv Health leaders Clifford McIntosh, Vice President of Strategic Alliance Management and Alexandria Wise-Rankovic, Ph.D., Senior Vice President of Clinical Development, CNS reveal a proven method to thrive in large, global, Phase III Programs.




Why Track and Trace Isn't Just Tracking and Tracing: Best Practices for Implementing a Solution That Works

Mon, 18 Sep 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - September 18, 2017) - In an upcoming webinar on Wednesday, October 4, 2017, industry expert Joe Lipari, Director of Cloud Products at Systech International will discuss a holistic approach towards designing and achieving a successful Track and Trace solution.




Daxor Corporation Forwarding Plans to Expand Impact at HFSA 2017 and Beyond

Fri, 15 Sep 2017 09:00:00 EDT

NEW YORK, NY--(Marketwired - Sep 15, 2017) - Daxor Corporation (NYSE MKT: DXR), an investment company with medical instrumentation and biotechnology operations, announced today that it will be exhibiting at the 21st meeting of the Heart Failure Society of America (HFSA) in Dallas, Texas, from September 16 through September 18, 2017, at booth 517. HFSA is well recognized as an outstanding forum for the presentation of the latest information on clinical and basic research, treatment and patient care in heart failure (HF), and is attended by key thought leaders and decision makers in the field.




Lugano 2014 Criteria for Assessing FDG-PET/CT in Lymphoma: An Operational Approach for Clinical Trials

Fri, 15 Sep 2017 08:15:21 EDT

The goal of this webinar hosted by Xtalks is to discuss the evolution of the role of imaging in the assessment of lymphomatous disease




Development and Manufacture of HPAPI Drug Products through the Clinical Phases from molecule to market, New Webinar Hosted by Xtalks

Fri, 15 Sep 2017 08:12:31 EDT

TORONTO, ON--(Marketwired - September 15, 2017) - This webinar will share how highly potent APIs can be developed and manufactured into suitable drug dosage forms including; solid oral, non-sterile oral liquids and semi-solid creams and ointments whilst adhering to the highest quality standards. Attendees will learn about the complexities at each stage of the development lifecycle, from the earliest phase of First in Man (FiM) studies involving drug in capsule, moving through ongoing clinical development and process optimization of often complex formulations ultimately resulting in commercialization and global supply.




Dewmar International BMC, Inc. (DEWM) Announces Synergy with Duck Commander CEO Willie Robertson for Donation of Medical Supplies and More to Hurricane Harvey Shelters

Fri, 15 Sep 2017 07:36:40 EDT

HOUSTON, TX--(Marketwired - Sep 15, 2017) - Dewmar International BMC, Inc. (OTC PINK: DEWM), a diversified brand management and operating company, announces that along with its operating partner, Willie Robertson, Dewmar and Mr. Robertson provided valuable donations of medical equipment, devices, clothing, outdoor wear and more to assist Hurricane Harvey victims and first-responders in the Greater Houston area.




Most Surveyed Pharma Companies Choose to Fund Dedicated Continuing Medical Education Programs

Thu, 14 Sep 2017 18:51:00 EDT

RESEARCH TRIANGLE PARK, NC--(Marketwired - September 14, 2017) - About 77% of surveyed global medical affairs teams consider dedicated CME providers as their first choice when funding continuing medical education (CME) programs, according to a recent study by industry intelligence provider, Cutting Edge Information.




ORHub (ORHB) Joins ICHOM TechHub to Propel Value-Driven Improvements in Healthcare

Thu, 14 Sep 2017 11:01:22 EDT

Poised to create the nation's largest repository of surgical outcomes, addressing significant patient concerns




Tauriga Sciences, Inc. Secures $210,000 in Long Term Financing from Existing Institutional Investor

Thu, 14 Sep 2017 10:26:28 EDT

NEW YORK, NY--(Marketwired - Sep 14, 2017) - Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), a company engaged in building businesses in the life sciences space, today announced that it has secured $210,000 in long term financing from an existing institutional investor. Under terms of the financing agreement, the Company received $30,000 USD upon signing with the balance of $180,000 being deferred until after March 11, 2018. The financing structure consists of one $30,000 convertible debenture with 6 distinct $30,000 "Back End" convertible debentures which are eligible to be funded at any time between March 11, 2018 -- September 11, 2018. A detailed disclosure of the material terms of this financing agreement will be provided to shareholders on Form 8-K to be filed by the Company within the next few business days.




CureDots(TM) Look to Redefine How Animal Clinical Trials Are Conducted -- CFN Media

Thu, 14 Sep 2017 09:30:00 EDT

SEATTLE, WA--(Marketwired - Sep 14, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article examining CURE Pharmaceutical's (OTCQB: CURR) recently developed CureDotsT, a more humane and effective technique for administering drugs to animals.




VirtualHealth Partners with Wellth to Drive Patient Adherence to Medications and Care Plans

Thu, 14 Sep 2017 09:00:00 EDT

NEW YORK, NY--(Marketwired - Sep 14, 2017) - VirtualHealth, the leading provider of population health and care management technologies, announced today its partnership with Wellth, a digital health company offering incentive-based behavioral change programs, to improve patient adherence to medications and care plans. The collaboration strengthens both organizations' missions to provide impactful solutions that help payers and providers succeed with value-based care by improving clinical outcomes and reducing costs associated with managing chronic conditions.




Medovex Corporation Initiates Forward Integration-Direct Sales Operations Strategy on Heels of Initial Strong Sales Opportunity in Key German Market

Thu, 14 Sep 2017 08:30:00 EDT

Gains a Strategic Edge Bringing Physicians, Hospitals and Patients Closer




Cannabis Science Announces Publication of Initial Research Results Using Nanoparticle Drones to Target Lung Cancer With Radiosensitizers and Cannabinoids in the Renowned Journal Frontiers in Oncology

Thu, 14 Sep 2017 08:05:22 EDT

IRVINE, CA--(Marketwired - Sep 14, 2017) -  Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces the publication of initial research results on using nanoparticle drones to target lung cancer with radiosensitizers and cannabinoids in the world-renowned cancer research journal Frontiers in Oncology.




Velano Vascular and Partners to Address Medical Device Innovation and Vascular Access Advances in September

Thu, 14 Sep 2017 08:05:00 EDT

SAN FRANCISCO, CA--(Marketwired - Sep 14, 2017) - Vascular access technology innovator Velano Vascular today announced that company leadership and several partners will present at a number of premier healthcare conferences in September.




Clinical Payments Case Studies: Improving Efficiency, Cash Management, and Compliance, New Webinar Hosted by Xtalks

Thu, 14 Sep 2017 08:00:00 EDT

TORONTO, ON--(Marketwired - September 14, 2017) - The live session taking place on Tuesday, September 26, 2017 at 11am EDT (4pm BST/UK) will present case studies of how trial sponsors and CROs are:




Why Phase 3 Trials Fail: Oncology Case Studies and Lessons Learned, Upcoming Webinar Hosted by Xtalks

Thu, 14 Sep 2017 07:30:00 EDT

TORONTO, ON --(Marketwired - September 14, 2017) - In this complimentary webinar taking place on Monday September 25, 2017,11am EDT (4pm BST/UK), a team of experts from Clinipace Worldwide will examine high-profile Phase 3 trial failures and discuss lessons learned.




Milestone Scientific Announces Children's Hospital of Pittsburgh to use The Wand(R) Computer Assisted Anesthesia System for Pediatric Patients

Thu, 14 Sep 2017 07:30:00 EDT

The Wand(R) incorporated into Pediatric Residency Program curriculum




Medix to Support HKU's Undiagnosed Disease Programme

Thu, 14 Sep 2017 05:28:35 EDT

HONG KONG, CHINA--(Marketwired - Sep 14, 2017) -  Medix announced today its partnership in supporting The University of Hong Kong's (HKU) programme for the advancement of knowledge, understanding and diagnosis of undiagnosed and rare diseases in children. The support will be of both financial contributions and access to peer to peer consultations with Medix's leading global specialists. These specialists would be able to provide additional information and insights, including overviews of current clinical trials and research to assist in reaching an accurate diagnosis for the programme's patients. 




Fresenius Medical Care unveils Malaysia's first Peritoneal Dialysis products Manufacturing Plant

Thu, 14 Sep 2017 01:22:31 EDT

SEREMBAN, MALAYSIA--(Marketwired - Sep 14, 2017) -  Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, expanded its regional manufacturing plant in Bandar Enstek, Malaysia. Dato' Seri Dr. Chen Chaw Min, Secretary General of the Malaysian Ministry of Health graced the opening ceremony.




ISQED 2018 Extends Paper Submission Deadline

Wed, 13 Sep 2017 17:55:09 EDT

Conference to Focus on Security, IoT, and Machine Learning in Electronic Design




Meta-Analyse zeigt, dass RenalGuard(R) einen enormen Vorteil bei Vermeidung eines kontrastmittelinduzierten akuten Nierenversagens bei Patienten bietet, die sich Herz-Kreislauf-Interventionen unterziehen

Wed, 13 Sep 2017 11:56:06 EDT

RenalGuard reduziert deutlich die AKI-Raten bei Patienten mit mittlerem bis hohem Risiko sowie mindert deutlich Todesfälle, Dialyse und ernste kardiovaskuläre Nebenwirkungen

Neue Meta-Analyse der Therapie mit RenalGuard (R) umfasst 3 Studien, die zeigen, dass RenalGuard während TAVR vor AKI schützt




UC Irvine Division of Continuing Education Offers Event to Educate Certificate Program Earners on the Opportunity to Apply Credits Towards a Master's Degree

Wed, 13 Sep 2017 11:40:00 EDT

Free Panel Discussion Held on Oct. 5 at UC Irvine Campus; Must Register to Attend




Une méta-analyse montre que RenalGuard(R) offre des bienfaits spectaculaires pour la prévention de l'insuffisance rénale aiguë induite par des produits de contraste chez les patients faisant l'objet d'interventions cardiovasculaires

Wed, 13 Sep 2017 11:27:39 EDT

RenalGuard a considérablement réduit les taux d'IRA chez des patients à risque modéré à élevé, ainsi que les décès, les dialyses et les événements cardiovasculaires indésirables graves

La nouvelle méta-analyse de RenalGuard Therapy(R) inclut 3 études montrant que RenalGuard protège de l'IRA pendant les procédures TAVR




On4 Communications Announces Major $1,000,000 Contract With Pennsylvania/New Jersey Dealer Group

Wed, 13 Sep 2017 11:00:21 EDT

NEW YORK, NY--(Marketwired - Sep 13, 2017) - On4 Communications, Inc. (OTC: ONCI) announces today that it has signed a major new contract with Pennsylvania/New Jersey dealer Group with brands including Jeep,Kia, Chevy, Ford, Alpha Romeo, GM, Hyundi and Nissan. 




Protext Pharma to Conduct Clinical Trial to Determine Therapeutic Dosage Levels for Treating Diabetes

Wed, 13 Sep 2017 10:16:58 EDT

Company's Near Term Goal to Sell Phytofare® as a Primary Therapy Protocol




etectRx, Inc. Announces Issuance of U.S. Patent for Ingestible Medication Compliance System

Wed, 13 Sep 2017 09:00:00 EDT

GAINESVILLE, FL--(Marketwired - September 13, 2017) - etectRx, Inc., an early stage digital health company, today announces that the United States Patent and Trademark Office has issued U.S. Patent 9,743,880 for an "Electronic Medication Compliance Monitoring System and Associated Methods." The patent covers an ingestible electronic tag system and a method for monitoring a patient's compliance with a medication program. etectRx has exclusive rights to the patented technology.




Redox and Academic Medical Center Collaborate to Scale Digital Health Innovation

Wed, 13 Sep 2017 09:00:00 EDT

Multi-year Agreement to Streamline Integrations Across the Organization




CFN Media Takes a Video Look into Future Farm's Cutting-Edge Facility

Wed, 13 Sep 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Sep 13, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, recently published an exclusive video that takes a look into Future Farm Technologies Inc.'s (CSE: FFT) (CNSX: FFT) (FFT.CN) (OTCQB: FFRMF) cutting-edge facility shortly before it harvested its first cannabis crop in California.




Meta-Analysis Shows RenalGuard(R) Offers Dramatic Benefit for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Cardiovascular Interventions

Wed, 13 Sep 2017 08:00:00 EDT

RenalGuard Significantly Reduced AKI Rates in Patients at Moderate to High Risk, as well as Significantly Decreased Deaths, Dialysis, and Major Adverse Cardiovascular Events

New Meta-Analysis of RenalGuard Therapy(R) Includes 3 Studies Showing RenalGuard Protects from AKI during TAVR




Innovation through Integration - Providing Next Generation Biomedical Devices and Interconnects

Wed, 13 Sep 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - September 13, 2017) - In a complementary Xtalks webinar scheduled for Friday, September 22, 2017 at 2pm EDT, industry expert Steve Groothuis, Chief Technology Officer at Samtec Microelectronics will provide insight into new packaging concepts, interconnects.




mCig, Inc. Raising up to $3 Million in Financing for Expansion of Operations

Wed, 13 Sep 2017 07:00:00 EDT

LAS VEGAS, NV--(Marketwired - Sep 13, 2017) - mCig Inc., (OTCQB: MCIG), a diversified company servicing the legal cannabis, hemp, and CBD markets, is pleased to announce that it is concluding efforts to raise up to $3 million under a private placement to qualified accredited investors for the expansion of its operations.